NasdaqGM - Nasdaq Real Time Price
USD
Altimmune, Inc. (ALT)
2.0850
+0.0450
(+2.21%)
As of 9:37:04 AM EST. Market Open.
Trade ALT on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreNews headlines
Powered by Yahoo ScoutAltimmune is advancing pemvidutide through a late-stage liver-disease pipeline spanning MASH, alcohol use disorder, and alcohol-associated liver disease. The company has started its pivotal Phase 3 MASH trial, reported positive Phase 2 alcohol-use results, and plans new data at AASLD The Liver Meeting 2026.
